Updates in the Early Management of Acute Spinal Cord Injury.

J Am Acad Orthop Surg · Jul 10 2023 · Review

Lambrechts MJ, Issa TZ, Hilibrand AS

From the Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, PA

Spine

SUMMARY — THE REDUCTIONReviews evolving evidence on early decompression, methylprednisolone, and blood pressure/CSF management strategies to optimize outcomes after acute spinal cord injury.
Abstract, as published

Spinal cord injury (SCI) is a leading cause of disability worldwide, and effective management is necessary to improve clinical outcomes. Many long-standing therapies including early reduction and spinal cord decompression, methylprednisolone administration, and optimization of spinal cord perfusion have been around for decades; however, their efficacy has remained controversial because of limited high-quality data. This review article highlights studies surrounding the role of early surgical decompression and its role in relieving mechanical pressure on the microvascular circulation thereby reducing intraspinal pressure. Furthermore, the article touches on the current role of methylprednisolone and identifies promising studies evaluating neuroprotective and neuroregenerative agents. Finally, this article outlines the expanding body of literature evaluating mean arterial pressure goals, cerebrospinal fluid drainage, and expansive duroplasty to further optimize vascularization to the spinal cord. Overall, this review aims to highlight evidence for SCI treatments and ongoing trials that may markedly affect SCI care in the near future.

Featured in the 2026-09-17 issue.

← Revision after spinal stenosis surgery.Radiologic and Clinical Importance of Lamina Hinge Fractures … →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.